Intra- and interassay coefficients of variation were 12.0% and 13.8%, based on average concentrations of 1.36 and 0.44 ng/mL, respectively
[DOI] [PubMed] [Google Scholar] Eng J., Kleinman W
Previous studies have reported the favorable clinical efficacy outcomes of different concentrations of topical kojic acid formulations either alone or in conjunction with other therapeutic agents (Monteiro et al., 2013
Researchers who treat MT-1 as a flexible cosmetic compound rather than a precision tool will consistently fail to replicate published results, not because the peptide doesn't work, but because the protocol wasn't followed with the rigour the compound requires
Injecting 37.5 units (0.375 mL) This smaller volume is much more comfortable
Six protocols cover the four main mechanism classes that 20 years of GLP-1 history produced: Microdose GLP-1 Protocol at $129/mo flat across four delivery formats (capsule, troche, lozenge, sublingual)